Biotech ETF breaks out as U.S. small-cap tech lags.

1 min read


  • Biotech ETFs such as XBI, BBC, and SBIO are seeing significant gains in 2024.
  • Small-cap technology stocks are lagging behind U.S. large-cap equities.

In 2024, several biotech ETFs, including XBI, BBC, and SBIO, have seen significant gains. The SPDR S&P Biotech ETF has surged over 10% year-to-date, with major components like biotech and retail stocks breaking out to two-year highs. On the other hand, small-cap technology stocks are lagging behind U.S. large-cap equities, with the Invesco S&P SmallCap Information Technology ETF falling 3.6% year-to-date despite a 0.9% increase in February.

DataTrek Research points out that small-cap tech stocks usually outperform small-cap equities but have been underperforming recently. However, history suggests that small-cap tech stocks may revert to the mean and outperform in the next few months. Overall, large-cap tech and U.S. large-cap equities are currently favored over small-cap counterparts in the market environment.

Previous Story

GigaOm’s Top Criteria for Evaluating Deception Tech Solutions

Next Story

Cutting-edge angling tech revolutionizes ice fishing, maximizing catch rates.

Latest from News